Regen BioPharma (RGBP) Stock Attempts To Recover: What’s The Buzz?

The Regen BioPharma Inc (OTCMKTS:RGBP) stock was on the move again this past Friday after it emerged that the company has started the process of reviving some of its patents.

It is a significant development since Regen since the patent applications that had submitted to the United States Patent and Trademark Office (USPTO) had earlier been classified as abandoned by the agency. It is a significant development for the company and it has led to considerable optimism among investors.

Marc Baumgartner, who represents the firm Baumgartner Patent Law is going to provide Regen Biopharma with the necessary legal help in order to revive these patents.

The lawyer is a seasoned player in the intellectual property law space and has total experience spanning two decades. After the massive rally last month, it seems that the Regen stock is now in the middle of another potential rally. Investors could consider watching the stock on Monday.